38 results
Keyword azacitidine Remove keyword
Categories
Human Remove Human filter
-
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 27-30 January 2020
CHMP, Last updated: 31/01/2020Azacitidine betapharm … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 December 2019
CHMP, Last updated: 13/12/2019Azacitidine Accord … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 June 2019
CHMP, Last updated: 28/06/2019Azacitidine Celgene … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 September 2015
CHMP, Last updated: 25/09/2015Name of medicine Vidaza INN azacitidine Marketing-authorisation holder … -
List item
Committee for Orphan Medicinal Products (COMP): 19-21 June 2018
European Medicines Agency, London, UK, from 19/06/2018 to 21/06/2018, Last updated: 17/08/2018 -
List item
Committee for Orphan Medicinal Products (COMP): 11-13 September 2018
European Medicines Agency, London, UK, from 11/09/2018 to 13/09/2018, Last updated: 06/12/2018 -
List item
Committee for Orphan Medicinal Products (COMP): 6-8 October 2015
European Medicines Agency, London, UK, from 06/10/2015 to 08/10/2015, Last updated: 27/09/201316 2.1.11. Azacitidine - EMA/OD/098/15 … -
List item
Committee for Orphan Medicinal Products (COMP): 10-11 April 2017
European Medicines Agency, London, UK, from 10/04/2017 to 11/04/2017, Last updated: 19/06/2014 -
List item
Committee for Orphan Medicinal Products (COMP): 22-24 May 2018
European Medicines Agency, London, UK, from 22/05/2018 to 24/05/2018, Last updated: 17/08/2018 -
List item
Workshop on site and histology - Independent indications in oncology
European Medicines Agency, London, UK, from 14/12/2017 to 15/12/2017, Last updated: 07/02/2018 -
List item
Committee for Orphan Medicinal Products (COMP): 10-12 November 2015
European Medicines Agency, London, UK, from 10/11/2015 to 12/11/2015, Last updated: 27/09/2013 -
List item
Committee for Orphan Medicinal Products (COMP): 8-10 December 2015
European Medicines Agency, London, UK, from 08/12/2015 to 10/12/2015, Last updated: 27/09/2013 -
List item
Committee for Medicinal Products for Human Use (CHMP): 21-24 September 2015
European Medicines Agency, London, UK, from 21/09/2015 to 24/09/2015, Last updated: 03/01/2014 -
List item
Committee for Orphan Medicinal Products (COMP): 17-19 April 2018
European Medicines Agency, London, UK, from 17/04/2018 to 19/04/2018, Last updated: 16/04/2018 -
List item
Committee for Orphan Medicinal Products (COMP): 11-13 July 2017
European Medicines Agency, London, UK, from 11/07/2017 to 13/07/2017, Last updated: 19/06/2014 -
List item
Committee for Orphan Medicinal Products (COMP): 17-19 January 2017
European Medicines Agency, London, UK, from 17/01/2017 to 19/01/2017, Last updated: 18/06/2014 -
List item
Committee for Orphan Medicinal Products (COMP): 19-21 January 2016
European Medicines Agency, London, UK, from 19/01/2016 to 21/01/2016, Last updated: 17/06/2014 -
List item
Committee for Orphan Medicinal Products (COMP): 17-19 July 2018
European Medicines Agency, London, UK, from 17/07/2018 to 19/07/2018, Last updated: 19/06/2014 -
List item
Committee for Orphan Medicinal Products (COMP): 21-23 March 2016
European Medicines Agency, London, UK, from 21/03/2016 to 23/03/2016, Last updated: 17/06/2016 -
List item
Committee for Orphan Medicinal Products (COMP): 13-15 June 2017
European Medicines Agency, London, UK, from 13/06/2017 to 15/06/2017, Last updated: 19/06/2014 -
List item
Committee for Orphan Medicinal Products (COMP): 13-15 March 2018
European Medicines Agency, London, UK, from 13/03/2018 to 15/03/2018, Last updated: 19/06/2014 -
List item
Committee for Orphan Medicinal Products (COMP): 14-15 March 2017
European Medicines Agency, London, UK, from 14/03/2017 to 15/03/2017, Last updated: 19/06/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 23-26 March 2015
European Medicines Agency, London, UK, from 23/03/2015 to 26/03/2015, Last updated: 03/01/2014 -
List item
Committee for Orphan Medicinal Products (COMP): 14-15 July 2015
European Medicines Agency, London, UK, from 14/07/2015 to 15/07/2015, Last updated: 26/09/2013 -
List item
Press release: 21st meeting of the Committee for Orphan Medicinal Products
COMP, Last updated: 27/02/2002Page 4/4 Active substance Azacitidine Sponsor Pharmion Limited …